Companies

CorMedix Inc. (CRMD) SEC filings

CIK 0001410098 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2022
Revenue (USD)311.7 M65408190936
Net income (USD)-29.7 M-28.2 M
Diluted EPS (USD/shares)2.04-0.91-0.74

Latest filings

FiledFormDescriptionPeriod
2026-10-198-KCURRENT REPORT items 7.01,9.012026-10-19
2026-09-18442026-09-18
2026-09-01442026-08-29
2026-09-01442026-08-29
2026-09-01442026-08-29
2026-08-1310-Q10-Q2026-06-30
2026-08-138-K8-K items 2.02,9.012026-08-13
2026-08-078-K8-K items 8.01,9.012026-08-07
2026-07-028-K8-K items 8.012026-06-29
2026-07-018-K8-K items 4.012026-06-25
2026-06-25S-8 POSS-8 POS
2026-06-248-K8-K items 5.072026-06-23
2026-06-12SCHEDULE 13G/ASCHEDULE 13G/A
2026-06-12SCHEDULE 13G/ASCHEDULE 13G/A
2026-06-088-KCURRENT REPORT items 7.01,9.012026-06-08
2026-05-15SCHEDULE 13G/ASCHEDULE 13G/A
2026-05-1410-Q10-Q2026-03-31
2026-05-148-K8-K items 2.02,9.012026-05-14
2026-04-29ARSARS2025-12-31
2026-04-29DEFA14ADEFINITIVE ADDITIONAL MATERIALS
2026-04-29DEF 14APROXY STATEMENT2026-06-23
2026-04-278-KCURRENT REPORT items 7.01,9.012026-04-27
2026-04-17PRE 14APROXY STATEMENT2026-04-17
2026-03-26SCHEDULE 13G/ASCHEDULE 13G/A
2026-03-068-KCURRENT REPORT items 7.01,9.012026-03-06

Forms on file (last 1,000): 4 404, 8-K 251, 10-Q 42, 3 28, 4/A 28, 424B5 21, DEF 14A 20, DEFA14A 18. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=CRMD (0.002 USD), /gw/filings/filings?ticker=CRMD&form=8-K, /gw/filings/facts?ticker=CRMD&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange